摘要
多肽药物具有生物活性高、药用剂量小、产业化开发优势明显等诸多优点,已成为全球关注的创新药物研发热点之一.但是其代谢不稳定、半衰期短及较难通透组织屏障等缺点严重阻碍了多肽新药在临床治疗中的广泛应用.为了解决这些限制多肽药物的瓶颈,本课题组发展了一系列的改造策略.通过这些策略的应用,以期加快多肽药物临床应用的步伐.本文主要结合本课题组的工作对多肽新药创制过程中所遇到的关键问题及解决思路进行综述.
The development of peptide drugs has become a global concern due to their merits such as high biological activity, low medicinal dose and easy to industrialization. However, low enzymatic stability, short half-life and low tissue permeability hamper the clinical application of nature peptide drugs. In order to overcome the bottlenecks, we developed a series of new modified strategies. By applications of these strategies, we wish to accelerate the pace of the development in clinical application of peptide drugs.
出处
《中国科学:化学》
CAS
CSCD
北大核心
2013年第8期941-952,共12页
SCIENTIA SINICA Chimica
基金
国家自然科学基金项目(91213302,20932003,21272102)
“重大新药创制”科技重大专项(2012ZX09504001-003)
长江学者和创新团队发展计划(IRT1137)的资助
关键词
多肽药物
神经肽
抗菌肽
靶向肽
穿膜肽
peptide drug
neuropeptide
antimicrobial peptide
targeting peptide
cell penetrating peptide